Rare in the trials, but a recognised concern with GLP-1 medications generally, partly because rapid weight loss itself can trigger gallstones
Regular check-ins let your provider fine-tune your dose, track your progress, and make sure the medication is doing its job safely
Kebeish R, El-Sayed A, Fahmy H, Abdel-Ghany A
Lysosomal storage disorders (LSDs) are a series of metabolic disorders that are mainly due to mutations in genes encoding proteolytic enzymes within lysosomes, resulting in the aggregation of relevant substrates and cell death (Zhao et al., 2003), Fabry disease (mutations in the -galactosidase A gene) (Suntjens et al., 2015), Pompe disease (mutations in the acid -glucosidase gene) (van Capelle et al., 2010), and -mannosidosis (mutations in the -mannosidosis gene) ( + into the lysosomes by the H + -ATPase pump